2022
DOI: 10.1016/j.ejro.2022.100453
|View full text |Cite
|
Sign up to set email alerts
|

Feasibility study of 2D Dixon-Magnetic Resonance Fingerprinting (MRF) of breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…It was found that this 2D MRF-Dixon technique produces clearer maps that show delineation between fibroglandular and fatty tissue and improved accuracy of T1 and T2 measurements. Zanderigo et al 135 performed validation of this technique in a prospective study on 14 patients with both precontrast and postcontrast MRF maps. They found that using MRF-Dixon, T1 and T2 values of breast cancer were significantly higher than fibroglandular tissue on precontrast maps (T1: P = 0.007; T2: P = 0.03).…”
Section: Current Clinical Applicationsmentioning
confidence: 99%
See 1 more Smart Citation
“…It was found that this 2D MRF-Dixon technique produces clearer maps that show delineation between fibroglandular and fatty tissue and improved accuracy of T1 and T2 measurements. Zanderigo et al 135 performed validation of this technique in a prospective study on 14 patients with both precontrast and postcontrast MRF maps. They found that using MRF-Dixon, T1 and T2 values of breast cancer were significantly higher than fibroglandular tissue on precontrast maps (T1: P = 0.007; T2: P = 0.03).…”
Section: Current Clinical Applicationsmentioning
confidence: 99%
“…Overall, the precontrast findings were similar to those obtained by Chen et al 133 and suggest potential use of MRF to supplement precontrast differentiation of breast tissue. 133,135 This remains to be validated on a larger scale.…”
Section: Breast Imagingmentioning
confidence: 99%